Aloe vera soup

PreclinicalBiologic

UUniversity of Thessaly

Aloe vera soup is one of 9 biologic programs targeting Recovery. It is currently in Preclinical.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

RecoveryCompleted

RecoveryPreclinical

Completed

Competition

Competitive Landscape

12 competitors in Recovery

#DrugCompanyPhaseTrials

Neurontin

VViatris Specialty LLC

Approved

3 2

Epidiolex

Jazz Pharmaceuticals

Phase 3

1 3

N-Acetyl-L-Cysteine

PPeking University People's Hospital

Phase 2

1 4

BXCL501

BBioXcel Therapeutics Inc

Phase 2

1 5

Blood Collection

AAssistance Publique - Hôpitaux de Paris

Preclinical

1 6

Bupivacaine-Fentanyl

SSamuel Lunenfeld Research Institute, Mount Sinai Hospital

Preclinical

1 7

Dual NRT

MMassachusetts General Hospital

Preclinical

1 8

L-Tyrosine

DDirection Centrale du Service de Santé des Armées

Preclinical

1 9

Aloe vera soup

UUniversity of Thessaly

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Recovery1 trial

Aloe Vera Ointment Application and Skeletal Muscle Recovery

Completed·UUniversity of Thessaly·N/A·NCT03934762·10 enrolled

Sources

References

[1]
ClinicalTrials.gov — 1 trial record for Aloe vera soup. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Aloe vera soup compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Aloe vera soup. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — University of Thessaly company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Biologic[2]
Highest Phase: Preclinical[1]
Company: UUniversity of Thessaly

Aloe vera soup

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Recovery1 trial

References

Drug Info

Quick Facts

Related News